Neo Announces Voting Results from Annual General Meeting of Shareholders
Werte in diesem Artikel
TORONTO, June 26, 2025 /CNW/ - Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) reports, in accordance with the policies of the Toronto Stock Exchange, the results of the matters put before shareholders for consideration and approving at the Company's annual general meeting of shareholders, as described in the management information circular dated May 21, 2025 are set out below. A total of 25.6 million common shares were voted in person or by proxy, representing 61.2% of the outstanding common shares.
Shareholders voted as follows:
Brief Description of Matter Voted Upon | Outcome of Vote | Common Shares Voted | ||
For | Withheld | |||
1. | Election of Directors In respect of the election of the following directors of the Company to serve until next annual meeting of the shareholders of the Company: | |||
Edgar Lee | Elected | 92.83 % | 7.17 % | |
Eric Noyrez | Elected | 94.70 % | 5.30 % | |
Rahim Suleman | Elected | 94.87 % | 5.13 % | |
G. Gail Edwards | Elected | 83.67 % | 16.33 % | |
Hua Du | Elected | 94.45 % | 5.55 % | |
Jonathan Evans | Elected | 94.89 % | 5.11 % | |
Paul Mascarena | Elected | 94.61 % | 5.39 % | |
2. | Re-Appointment of Auditors In respect of the re-appointment KPMG LLP, Chartered Accountants, as the auditors of the Company until the close of next annual meeting and authorizing the directors of the Company to fix their remuneration | Approved | 99.78 % | 0.22 % |
Cautionary Statements Regarding Forward Looking Statements
This news release contains "forward-looking information" within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this news release, other than statements of historical facts, with respect to Neo's objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions are forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "continues", "forecasts", "projects", "predicts", "intends", "anticipates" or "believes", or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results "may", "could", "would", "should", "might" or "will" be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review Neo's continuous disclosure filings available under its profile at www.sedarplus.ca. Information contained in forward-looking statements in this press release is provided as of the date hereof and Neo disclaims any obligation to update any forward-looking information, whether as a result of new information or future events or results, except to the extent required by applicable securities laws.
About Neo Performance Materials
Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials – magnetic powders, rare earth magnets, magnetic assemblies, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo's products fast-forward technologies for the net-zero transition. The business of Neo is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, United States; Singapore; and Beijing, China. Neo has a global platform that includes manufacturing facilities located in China, Germany, Canada, Estonia, Thailand and the United Kingdom, as well as one dedicated research and development centre in Singapore. For more information, please visit www.neomaterials.com.
SOURCE Neo Performance Materials, Inc.
Übrigens: Neogenomics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Neogenomics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Neogenomics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Neogenomics IncShs
Analysen zu Neogenomics IncShs
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2019 | Neogenomics Buy | Needham & Company, LLC | |
29.03.2019 | Neogenomics Buy | Needham & Company, LLC | |
03.01.2019 | Neogenomics Buy | Needham & Company, LLC | |
24.10.2018 | Neogenomics Strong Buy | First Analysis Securities | |
02.05.2018 | Neogenomics Equal-Weight | First Analysis Securities |
Datum | Rating | Analyst | |
---|---|---|---|
01.05.2019 | Neogenomics Buy | Needham & Company, LLC | |
29.03.2019 | Neogenomics Buy | Needham & Company, LLC | |
03.01.2019 | Neogenomics Buy | Needham & Company, LLC | |
24.10.2018 | Neogenomics Strong Buy | First Analysis Securities | |
24.08.2017 | Neogenomics Buy | Gabelli & Co |
Datum | Rating | Analyst | |
---|---|---|---|
02.05.2018 | Neogenomics Equal-Weight | First Analysis Securities | |
11.09.2017 | Neogenomics Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
21.08.2007 | Neogenomics konsequent zurückziehen | Global Biotech Investing |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogenomics IncShs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen